NCT02204059View on ClinicalTrials.gov

Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Non-small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

February 28, 2001

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

hMAb BIWA 4

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY